Cetera Investment Advisers
VYGR icon

Cetera Investment Advisers’s Voyager Therapeutics VYGR Stock Holding History

Cetera Investment Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.1K Buy
14,264
+100
+0.7% +$394 ﹤0.01% 4568
2025
Q4 		$55.7K Hold
14,164
– – ﹤0.01% 4491
2025
Q3 		$66.1K Buy
+14,164
New +$51.2K ﹤0.01% 4397

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cetera Investment Advisers's VYGR Position: Q1 2026 in Review

Cetera Investment Advisers increased its Voyager Therapeutics (VYGR) stake by 0.71% in Q1 2026, buying an estimated $394 and bringing the position to 14,264 shares worth $55.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4568.

Cetera Investment Advisers first reported a position in VYGR in Q3 2025 and has held it in 3 quarters since. The position peaked at $66.1K in Q3 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Cetera Investment Advisers held 14,264 shares of Voyager Therapeutics worth $55.1K as of Q1 2026.
  • Cetera Investment Advisers bought 100 Voyager Therapeutics shares in Q1 2026, an estimated $394.
  • Voyager Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4568 holding.
  • Cetera Investment Advisers first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Voyager Therapeutics position peaked at $66.1K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.